LinkedIn Profile

Access MerLion Pharmaceuticals historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:merlionpharmaceuticals 2497942 May 29th, 2019 12:00AM MerLion Pharmaceuticals Pte Ltd 2.3K 13.00 Open Pharmaceuticals May 29th, 2019 07:18PM May 29th, 2019 07:18PM We are a leading natural product based research and development company headquartered in Singapore, with clinical development operations based in Berlin, Germany. The company is organised into two key business units, MerLion Research and MerLion Development. MerLion Research is the company’s contract services business that has been created to exploit MerLion’s unique natural products discovery capabilities in the pharma, industrial biotechnology, agroscience, functional foods, flavourings, cosmetics and personal healthcare sectors. MerLion Research provides access to one of the world’s largest and most diverse natural product collections by offering sample/extract supply services, extract profiling and standardisation, assay development, high throughput screening, compound purification and structural identification, biocatalyst isolation and strain improvement. MerLion Development is progressing finafloxacin, a novel, highly differentiated antibacterial candidate, through Phase II clinical trials. The compound, which has already shown potential for the eradication of Helicobacter pylori and treatment of urinary tract infections, is being evaluated in critical core and hospital indications. In addition to finafloxacin, the company has a portfolio of earlier-stage, preclinical antibacterial and oncology programmes. Open Extract & Compound Supply, Screening & Assay Development, Chemistry & Analytical, Fermentation & Taxonomic Open 1 Science Park Road, The Capricorn, #05-01, Singapore Science Park 2 Singapore Singapore SG 117528 MerLion Pharmaceuticals Household Goods
private:merlionpharmaceuticals 2497942 Feb 17th, 2018 12:00AM MerLion Pharmaceuticals Pte Ltd 2.1K 11.00 Open Pharmaceuticals Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM We are a leading natural product based research and development company headquartered in Singapore, with clinical development operations based in Berlin, Germany. The company is organised into two key business units, MerLion Research and MerLion Development. MerLion Research is the company’s contract services business that has been created to exploit MerLion’s unique natural products discovery capabilities in the pharma, industrial biotechnology, agroscience, functional foods, flavourings, cosmetics and personal healthcare sectors. MerLion Research provides access to one of the world’s largest and most diverse natural product collections by offering sample/extract supply services, extract profiling and standardisation, assay development, high throughput screening, compound purification and structural identification, biocatalyst isolation and strain improvement. MerLion Development is progressing finafloxacin, a novel, highly differentiated antibacterial candidate, through Phase II clinical trials. The compound, which has already shown potential for the eradication of Helicobacter pylori and treatment of urinary tract infections, is being evaluated in critical core and hospital indications. In addition to finafloxacin, the company has a portfolio of earlier-stage, preclinical antibacterial and oncology programmes. MerLion Pharmaceuticals Household Goods
private:merlionpharmaceuticals 2497942 Feb 16th, 2018 12:00AM MerLion Pharmaceuticals Pte Ltd 2.1K 11.00 Open Pharmaceuticals Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM We are a leading natural product based research and development company headquartered in Singapore, with clinical development operations based in Berlin, Germany. The company is organised into two key business units, MerLion Research and MerLion Development. MerLion Research is the company’s contract services business that has been created to exploit MerLion’s unique natural products discovery capabilities in the pharma, industrial biotechnology, agroscience, functional foods, flavourings, cosmetics and personal healthcare sectors. MerLion Research provides access to one of the world’s largest and most diverse natural product collections by offering sample/extract supply services, extract profiling and standardisation, assay development, high throughput screening, compound purification and structural identification, biocatalyst isolation and strain improvement. MerLion Development is progressing finafloxacin, a novel, highly differentiated antibacterial candidate, through Phase II clinical trials. The compound, which has already shown potential for the eradication of Helicobacter pylori and treatment of urinary tract infections, is being evaluated in critical core and hospital indications. In addition to finafloxacin, the company has a portfolio of earlier-stage, preclinical antibacterial and oncology programmes. MerLion Pharmaceuticals Household Goods
private:merlionpharmaceuticals 2497942 Feb 15th, 2018 12:00AM MerLion Pharmaceuticals Pte Ltd 2.1K 11.00 Open Pharmaceuticals Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM We are a leading natural product based research and development company headquartered in Singapore, with clinical development operations based in Berlin, Germany. The company is organised into two key business units, MerLion Research and MerLion Development. MerLion Research is the company’s contract services business that has been created to exploit MerLion’s unique natural products discovery capabilities in the pharma, industrial biotechnology, agroscience, functional foods, flavourings, cosmetics and personal healthcare sectors. MerLion Research provides access to one of the world’s largest and most diverse natural product collections by offering sample/extract supply services, extract profiling and standardisation, assay development, high throughput screening, compound purification and structural identification, biocatalyst isolation and strain improvement. MerLion Development is progressing finafloxacin, a novel, highly differentiated antibacterial candidate, through Phase II clinical trials. The compound, which has already shown potential for the eradication of Helicobacter pylori and treatment of urinary tract infections, is being evaluated in critical core and hospital indications. In addition to finafloxacin, the company has a portfolio of earlier-stage, preclinical antibacterial and oncology programmes. MerLion Pharmaceuticals Household Goods
private:merlionpharmaceuticals 2497942 Feb 14th, 2018 12:00AM MerLion Pharmaceuticals Pte Ltd 2.1K 11.00 Open Pharmaceuticals Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM We are a leading natural product based research and development company headquartered in Singapore, with clinical development operations based in Berlin, Germany. The company is organised into two key business units, MerLion Research and MerLion Development. MerLion Research is the company’s contract services business that has been created to exploit MerLion’s unique natural products discovery capabilities in the pharma, industrial biotechnology, agroscience, functional foods, flavourings, cosmetics and personal healthcare sectors. MerLion Research provides access to one of the world’s largest and most diverse natural product collections by offering sample/extract supply services, extract profiling and standardisation, assay development, high throughput screening, compound purification and structural identification, biocatalyst isolation and strain improvement. MerLion Development is progressing finafloxacin, a novel, highly differentiated antibacterial candidate, through Phase II clinical trials. The compound, which has already shown potential for the eradication of Helicobacter pylori and treatment of urinary tract infections, is being evaluated in critical core and hospital indications. In addition to finafloxacin, the company has a portfolio of earlier-stage, preclinical antibacterial and oncology programmes. MerLion Pharmaceuticals Household Goods
private:merlionpharmaceuticals 2497942 Feb 13th, 2018 12:00AM MerLion Pharmaceuticals Pte Ltd 2.1K 11.00 Open Pharmaceuticals Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM We are a leading natural product based research and development company headquartered in Singapore, with clinical development operations based in Berlin, Germany. The company is organised into two key business units, MerLion Research and MerLion Development. MerLion Research is the company’s contract services business that has been created to exploit MerLion’s unique natural products discovery capabilities in the pharma, industrial biotechnology, agroscience, functional foods, flavourings, cosmetics and personal healthcare sectors. MerLion Research provides access to one of the world’s largest and most diverse natural product collections by offering sample/extract supply services, extract profiling and standardisation, assay development, high throughput screening, compound purification and structural identification, biocatalyst isolation and strain improvement. MerLion Development is progressing finafloxacin, a novel, highly differentiated antibacterial candidate, through Phase II clinical trials. The compound, which has already shown potential for the eradication of Helicobacter pylori and treatment of urinary tract infections, is being evaluated in critical core and hospital indications. In addition to finafloxacin, the company has a portfolio of earlier-stage, preclinical antibacterial and oncology programmes. MerLion Pharmaceuticals Household Goods
private:merlionpharmaceuticals 2497942 Feb 12th, 2018 12:00AM MerLion Pharmaceuticals Pte Ltd 2.1K 11.00 Open Pharmaceuticals Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM We are a leading natural product based research and development company headquartered in Singapore, with clinical development operations based in Berlin, Germany. The company is organised into two key business units, MerLion Research and MerLion Development. MerLion Research is the company’s contract services business that has been created to exploit MerLion’s unique natural products discovery capabilities in the pharma, industrial biotechnology, agroscience, functional foods, flavourings, cosmetics and personal healthcare sectors. MerLion Research provides access to one of the world’s largest and most diverse natural product collections by offering sample/extract supply services, extract profiling and standardisation, assay development, high throughput screening, compound purification and structural identification, biocatalyst isolation and strain improvement. MerLion Development is progressing finafloxacin, a novel, highly differentiated antibacterial candidate, through Phase II clinical trials. The compound, which has already shown potential for the eradication of Helicobacter pylori and treatment of urinary tract infections, is being evaluated in critical core and hospital indications. In addition to finafloxacin, the company has a portfolio of earlier-stage, preclinical antibacterial and oncology programmes. MerLion Pharmaceuticals Household Goods
private:merlionpharmaceuticals 2497942 Feb 11th, 2018 12:00AM MerLion Pharmaceuticals Pte Ltd 2.1K 11.00 Open Pharmaceuticals Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM We are a leading natural product based research and development company headquartered in Singapore, with clinical development operations based in Berlin, Germany. The company is organised into two key business units, MerLion Research and MerLion Development. MerLion Research is the company’s contract services business that has been created to exploit MerLion’s unique natural products discovery capabilities in the pharma, industrial biotechnology, agroscience, functional foods, flavourings, cosmetics and personal healthcare sectors. MerLion Research provides access to one of the world’s largest and most diverse natural product collections by offering sample/extract supply services, extract profiling and standardisation, assay development, high throughput screening, compound purification and structural identification, biocatalyst isolation and strain improvement. MerLion Development is progressing finafloxacin, a novel, highly differentiated antibacterial candidate, through Phase II clinical trials. The compound, which has already shown potential for the eradication of Helicobacter pylori and treatment of urinary tract infections, is being evaluated in critical core and hospital indications. In addition to finafloxacin, the company has a portfolio of earlier-stage, preclinical antibacterial and oncology programmes. MerLion Pharmaceuticals Household Goods
private:merlionpharmaceuticals 2497942 Feb 10th, 2018 12:00AM MerLion Pharmaceuticals Pte Ltd 2.1K 11.00 Open Pharmaceuticals Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM We are a leading natural product based research and development company headquartered in Singapore, with clinical development operations based in Berlin, Germany. The company is organised into two key business units, MerLion Research and MerLion Development. MerLion Research is the company’s contract services business that has been created to exploit MerLion’s unique natural products discovery capabilities in the pharma, industrial biotechnology, agroscience, functional foods, flavourings, cosmetics and personal healthcare sectors. MerLion Research provides access to one of the world’s largest and most diverse natural product collections by offering sample/extract supply services, extract profiling and standardisation, assay development, high throughput screening, compound purification and structural identification, biocatalyst isolation and strain improvement. MerLion Development is progressing finafloxacin, a novel, highly differentiated antibacterial candidate, through Phase II clinical trials. The compound, which has already shown potential for the eradication of Helicobacter pylori and treatment of urinary tract infections, is being evaluated in critical core and hospital indications. In addition to finafloxacin, the company has a portfolio of earlier-stage, preclinical antibacterial and oncology programmes. MerLion Pharmaceuticals Household Goods
private:merlionpharmaceuticals 2497942 Feb 9th, 2018 12:00AM MerLion Pharmaceuticals Pte Ltd 2.1K 11.00 Open Pharmaceuticals Feb 9th, 2017 08:57AM Feb 9th, 2017 08:57AM We are a leading natural product based research and development company headquartered in Singapore, with clinical development operations based in Berlin, Germany. The company is organised into two key business units, MerLion Research and MerLion Development. MerLion Research is the company’s contract services business that has been created to exploit MerLion’s unique natural products discovery capabilities in the pharma, industrial biotechnology, agroscience, functional foods, flavourings, cosmetics and personal healthcare sectors. MerLion Research provides access to one of the world’s largest and most diverse natural product collections by offering sample/extract supply services, extract profiling and standardisation, assay development, high throughput screening, compound purification and structural identification, biocatalyst isolation and strain improvement. MerLion Development is progressing finafloxacin, a novel, highly differentiated antibacterial candidate, through Phase II clinical trials. The compound, which has already shown potential for the eradication of Helicobacter pylori and treatment of urinary tract infections, is being evaluated in critical core and hospital indications. In addition to finafloxacin, the company has a portfolio of earlier-stage, preclinical antibacterial and oncology programmes. MerLion Pharmaceuticals Household Goods

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.